Medtide

Medtide Inventory

The Inventory of Medtide (3880.HK) as of Oct 16, 2026 is 103.43 M CNY. In the previous year, Inventory was 84.78 M CNY — a change of 22.00% (higher).

Inventory

103.43 MCNY

YoY

22.00%

Last updated:

Inventory of Medtide is 2025 103.43 M CNY. Inventory of Medtide was 2024 84.78 M CNY. It decreases by 22.00% higher compared to the previous year.

The Medtide Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2021
67.49 M CNY
Jan 1, 2022
79.31 M CNY
Jan 1, 2023
73.01 M CNY
Jan 1, 2024
84.78 M CNY
Jan 1, 2025
103.43 M CNY
The Medtide Inventory history
YEARInventoryYoY
103.43 MCNY+22.00%
84.78 MCNY+16.12%
73.01 MCNY-7.94%
79.31 MCNY+17.51%
67.49 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medtide Stock analysis

What does Medtide do? Medtide Inc, listed on the Hong Kong Stock Exchange under ticker 3880.HK, is a life sciences company headquartered in Hangzhou, China. The company, which has 522 full-time employees, specializes in peptide-focused contract research, development, and manufacturing services. Medtide provides contract research organization (CRO) services, including peptide new chemical entity (NCE) discovery and synthesis, as well as contract development and manufacturing organization (CDMO) services covering peptide chemistry, manufacturing, and control (CMC) development and commercial manufacturing. The company's primary focus is on delivering active pharmaceutical ingredients (APIs) rather than finished drug products. Medtide also offers peptide drug development, production, and CMC filing support services to its clients. The firm serves both domestic and international markets, operating across multiple regions. Medtide's initial public offering (IPO) is scheduled for June 30, 2025, as indicated by its IPO date. The company's website is http://medtideinc.com, where further information about its services and operations can be found. Medtide Inc. operates within the Health Care sector, specifically in the Life Sciences Tools & Services industry, reflecting its specialized role in the pharmaceutical and biotechnology fields. The company's business model centers on providing comprehensive solutions for peptide-based drug development and manufacturing, targeting clients seeking expertise in this niche area of pharmaceutical services. Medtide is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medtide stock

Inventory of Medtide is 103.43 M CNY in 2025.

Inventory of Medtide changed from 84.78 M CNY to 103.43 M CNY, representing a 22.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Medtide since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Medtide historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Medtide

All Key Metrics — Medtide